The blood-based test by Astrin Biosciences shows high sensitivity and specificity across cancer stages and subtypes, addressing mammography's limitations in dense breast tissue. The test achieved 92.3 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback